CLEVIPREX 50MG/100ML: payments to doctors
Payments that named CLEVIPREX 50MG/100ML as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $28K
- Providers
- 740
- Transactions
- 1,116
- Average per transaction
- $25
The per-transaction average — $25 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 740 providers the average total is $37, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Chiesi USA, Inc. | $27,744 | 100.0% |